Author

Mark R. Litzow

Observed names: Litzow MR, M R Litzow

Institution: Mayo Clinic

Observed institution: Mayo Clinic

ORCID: 0000-0002-9816-6302

Observed ORCID: 0000-0002-9816-6302

OpenAlex ID: A5000489875

Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemia.

2001 · A B Dietz, M R Litzow, et al. · PubMed · 14

Using Next-Generation Sequencing to Find Targetable Genomic Lesions in a Case of Relapsed Extramedullary Acute Myeloid Leukemia

2017 · Litzow MR · Annals of Hematology & Oncology · 1

Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia

2026 · Jaewoong Lee, Ruifeng Sun, et al. · Science Signaling

The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia – A Single Center Retrospective Study

2021 · Liu Q, Major B, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]

2018 · Anagnostou T, Litzow MR · DOAJ (DOAJ: Directory of Open Access Journals)

Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab

2014 · Litzow MR · DOAJ (DOAJ: Directory of Open Access Journals)

Works count: 7

Citation count: 15

H-index: 1

I10-index: 1